Home/Filings/4/0001209191-23-059631
4//SEC Filing

Graves Michael 4

Accession 0001209191-23-059631

CIK 0000827871other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 7:00 PM ET

Size

5.8 KB

Accession

0001209191-23-059631

Insider Transaction Report

Form 4
Period: 2023-12-21
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-12-21+293,000293,000 total
    Exercise: $5.01Exp: 2033-12-20Common Stock (293,000 underlying)
Footnotes (1)
  • [F1]The option was granted in connection with the Reporting Person's appointment as Interim Executive Chairman and Interim Principal Executive Officer. The option vests in 12 equal monthly installments commencing on November 27, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1
  • filerCIK 0001339978

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 7:00 PM ET
Size
5.8 KB